Patents Assigned to INIPHARM, INC.
  • Dichlorophenol HSD17B13 inhibitors and uses thereof
    Patent number: 12227489
    Abstract: Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).
    Type: Grant
    Filed: October 2, 2023
    Date of Patent: February 18, 2025
    Assignee: INIPHARM, INC.
    Inventors: Sampath Kumar Anandan, Joshua Odingo, Heather Kay Webb Hsu, Vincent Florio, Subramanyam Janardhan Tantry, Athisayamani Jeyaraj Duraiswamy
  • Dichlorophenol HSD17B13 inhibitors and uses thereof
    Patent number: 11827619
    Abstract: Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).
    Type: Grant
    Filed: May 10, 2023
    Date of Patent: November 28, 2023
    Assignee: INIPHARM, INC.
    Inventors: Sampath Kumar Anandan, Joshua Odingo, Heather Kay Webb Hsu, Vincent Florio, Subramanyam Janardhan Tantry, Athisayamani Jeyaraj Duraiswamy